rare diseases, cell & molecular biology, developmental biology
Shire to Buy Baxalta for $32 Billion
Shire to Buy Baxalta for $32 Billion
Tracy Vence | Jan 12, 2016
The Dublin-based pharma giant is set to acquire Baxalta, an Illinois-based Baxter spinoff, expanding its rare disease drug portfolio.
How Multicellularity Arose
How Multicellularity Arose
Jef Akst | Jan 11, 2016
Researchers identify a molecule that may have been key to the surprisingly common transition from single-celled ancestors to today’s complex, multicellular organisms. 
Molecular Fingerprint Predicts Flu Shot Response
Molecular Fingerprint Predicts Flu Shot Response
Jyoti Madhusoodanan | Jan 4, 2016
A gene-expression signature correlates with a person’s likelihood of experiencing adverse events after receiving a seasonal flu vaccine, scientists show. 
Master Folder
Master Folder
The Scientist Staff | Jan 1, 2016
Meet Susan Lindquist, the MIT biologist who has won numerous accolades for her research on protein folding.
Fearless about Folding
Fearless about Folding
Anna Azvolinsky | Jan 1, 2016
Susan Lindquist has never shied away from letting her curiosity guide her research career.
Smooth Move
Smooth Move
Ashley P. Taylor | Jan 1, 2016
In the mouse lung, hardening of a blood vessel can result from just a single progenitor cell forming new smooth muscle.
Discoverer of G Proteins Dies
Discoverer of G Proteins Dies
Kerry Grens | Dec 29, 2015
Nobel laureate Alfred Gilman has passed away at age 74.
Year in Review: Hot Topics
Year in Review: Hot Topics
Jef Akst | Dec 21, 2015
In 2015, The Scientist dove deep into the latest research on aging, HIV, hearing, and obesity.
Gia Voeltz: Cellular Cartographer
Gia Voeltz: Cellular Cartographer
Karen Zusi | Dec 1, 2015
Associate Professor, Department of Molecular, Cellular, and Developmental Biology, University of Colorado, Boulder. Age: 43
Carry-On Luggage
Carry-On Luggage
Kerry Grens | Dec 1, 2015
Without a vacuole, cell-cycle progression stalls out in yeast cells.